J. H. Doroshow
- Oncology top 10%
- Colorectal Cancer Treatments and Studies 6
- CAR-T cell therapy research 3
- Cancer Treatment and Pharmacology 3
-
- Cancer therapeutics and mechanisms 6
-
- Radiopharmaceutical Chemistry and Applications 3
-
- Hepatocellular Carcinoma Treatment and Prognosis 3
-
- Neuroblastoma Research and Treatments 3
-
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Kim MargolinPatricia S. BralyJames RaschkoGeorge SomloL. LeongLawrence E. WilliamsFrederick R. AronsonDave Yamauchi
- Journals
- Journal of Clinical Oncology (13 papers)Blood (2 papers)JNCI Journal of the National Cancer Institute (2 papers)
- Partner nations
- United StatesCanadaMalaysia
In The Last Decade
J. H. Doroshow
29 papers receiving 521 citations
Peers
Comparison fields: 5 of 77
- Oncology 247
- Immunology 99
- Reproductive Medicine 36
- Hematology 45
- Cancer Research 48
Countries citing papers authored by J. H. Doroshow
This map shows the geographic impact of J. H. Doroshow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. H. Doroshow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. H. Doroshow more than expected).
Fields of papers citing papers by J. H. Doroshow
This network shows the impact of papers produced by J. H. Doroshow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. H. Doroshow. The network helps show where J. H. Doroshow may publish in the future.
Co-authorship network
The 25 scholars most cited alongside J. H. Doroshow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 19 | |
| 2 | 2007 | 54 | |
| 3 | 2004 | 14 | |
| 4 | 2004 | 1 | |
| 5 | A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies. | 2000 | 63 |
| 6 | 2000 | 15 | |
| 7 | 1998 | 6 | |
| 8 | 1997 | 1 | |
| 9 | 1995 | 13 | |
| 10 | 1995 | 21 | |
| 11 | 1994 | 51 | |
| 12 | 1993 | 1 | |
| 13 | 1992 | 12 | |
| 14 | 1992 | 34 | |
| 15 | 1992 | 19 | |
| 16 | 1991 | 9 | |
| 17 | 1990 | 34 | |
| 18 | 1990 | 2 | |
| 19 | 1990 | 48 | |
| 20 | 1986 | 32 |
About J. H. Doroshow
J. H. Doroshow is a scholar working on Oncology, Hepatology and Cancer Research, having authored 30 papers that have together received 543 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (6 papers), Cancer therapeutics and mechanisms (6 papers), Radiopharmaceutical Chemistry and Applications (3 papers), CAR-T cell therapy research (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Neuroblastoma Research and Treatments (3 papers), Cancer Treatment and Pharmacology (3 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Oncology (247 citations), Immunology (99 citations) and Reproductive Medicine (36 citations). J. H. Doroshow has collaborated with scholars based in United States, Canada and Malaysia. Frequent co-authors include Kim Margolin, Patricia S. Braly, James Raschko, George Somlo, L. Leong, Lawrence E. Williams, Frederick R. Aronson, Dave Yamauchi, Andrew Raubitschek and Geoffrey R. Weiss. Their work appears in journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.